Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Malaysian (KLSE) Pharma Industry Analysis

UpdatedJan 29, 2026
DataAggregated Company Financials
Companies5
  • 7D2.9%
  • 3M5.3%
  • 1Y6.7%
  • YTD6.1%

The Pharma industry is up 1.7% in the last week, with Duopharma Biotech Berhad up 6.1%. This means that the industry has gained 6.6% over the past year. Earnings are forecast to grow by 13% annually.

Industry Valuation and Performance

Has the Malaysian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 29 Jan 2026RM 2.5bRM 1.9bRM 166.4m14.3x14.9x1.3x
Sat, 27 Dec 2025RM 4.3bRM 2.8bRM 231.9m14.5x18.3x1.5x
Mon, 24 Nov 2025RM 4.2bRM 2.8bRM 233.3m14.6x18x1.5x
Wed, 22 Oct 2025RM 4.1bRM 2.8bRM 223.3m15.3x18.4x1.5x
Fri, 19 Sep 2025RM 4.2bRM 2.8bRM 223.3m16.1x18.9x1.5x
Sun, 17 Aug 2025RM 4.2bRM 2.8bRM 231.0m15.5x18.2x1.5x
Tue, 15 Jul 2025RM 4.2bRM 2.8bRM 230.3m16.1x18x1.5x
Thu, 12 Jun 2025RM 4.1bRM 2.8bRM 230.3m16x17.6x1.4x
Sat, 10 May 2025RM 3.8bRM 2.8bRM 221.0m17x17.4x1.4x
Mon, 07 Apr 2025RM 3.8bRM 2.8bRM 221.0m16x17.1x1.4x
Wed, 05 Mar 2025RM 3.9bRM 2.8bRM 221.0m16.3x17.4x1.4x
Fri, 31 Jan 2025RM 4.1bRM 2.7bRM 223.9m16.6x18.2x1.5x
Sun, 29 Dec 2024RM 4.2bRM 2.7bRM 223.9m17.3x18.6x1.5x
Tue, 26 Nov 2024RM 4.2bRM 2.7bRM 234.3m14x18x1.5x
Thu, 24 Oct 2024RM 4.4bRM 2.7bRM 230.0m14.3x19x1.6x
Sat, 21 Sep 2024RM 4.3bRM 2.7bRM 230.0m14.8x18.9x1.6x
Mon, 19 Aug 2024RM 4.3bRM 2.7bRM 545.6m12.5x7.9x1.6x
Wed, 17 Jul 2024RM 4.5bRM 2.6bRM 541.3m13x8.3x1.7x
Fri, 14 Jun 2024RM 4.6bRM 2.6bRM 541.3m13.4x8.4x1.7x
Sun, 12 May 2024RM 4.9bRM 2.6bRM 559.3m12.4x8.7x1.9x
Tue, 09 Apr 2024RM 4.6bRM 2.6bRM 559.3m12.4x8.1x1.7x
Thu, 07 Mar 2024RM 4.5bRM 2.6bRM 559.3m12.6x8.1x1.7x
Sat, 03 Feb 2024RM 4.5bRM 2.6bRM 584.9m12.1x7.7x1.8x
Mon, 01 Jan 2024RM 4.3bRM 2.6bRM 584.9m12.4x7.3x1.7x
Wed, 29 Nov 2023RM 4.2bRM 2.6bRM 591.7m12.1x7.1x1.6x
Fri, 27 Oct 2023RM 4.2bRM 2.6bRM 604.4m12.1x7x1.6x
Sun, 24 Sep 2023RM 4.3bRM 2.6bRM 604.4m12.8x7.1x1.7x
Tue, 22 Aug 2023RM 4.4bRM 2.6bRM 304.2m13.9x14.5x1.7x
Thu, 20 Jul 2023RM 4.4bRM 2.6bRM 304.7m14.6x14.4x1.7x
Sat, 17 Jun 2023RM 4.4bRM 2.6bRM 304.7m14.2x14.3x1.7x
Mon, 15 May 2023RM 4.6bRM 2.5bRM 289.8m13.4x16x1.9x
Wed, 12 Apr 2023RM 4.8bRM 2.5bRM 289.8m13.4x16.5x1.9x
Fri, 10 Mar 2023RM 4.8bRM 2.5bRM 289.8m13.8x16.5x1.9x
Sun, 05 Feb 2023RM 4.6bRM 2.4bRM 270.7m13.3x16.9x1.9x
Price to Earnings Ratio

16.9x


Total Market Cap: RM 4.6bTotal Earnings: RM 270.7mTotal Revenue: RM 2.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Malaysian Pharma Industry Price to Earnings3Y Average 14.2x202420252026
Current Industry PE
  • Investors are optimistic on the Malaysian Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 18.8x which is higher than its 3-year average PE of 14.2x.
  • The industry is trading close to its 3-year average PS ratio of 1.6x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 5.0% per year over the last three years.
  • Meanwhile revenues for these companies have grown 4.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Malaysian Healthcare industry?

MY Market1.73%
Healthcare5.03%
Pharma2.85%
Pharma2.85%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
DPHARMA Duopharma Biotech BerhadRM 1.396.1%
+RM 77.0m		14.9%PE16x

Latest News

RHONEMA
RM 0.69
Rhone Ma Holdings Berhad
7D
-0.7%
1Y
0.7%
PLABS
RM 0.27
PeterLabs Holdings Berhad
7D
-1.8%
1Y
42.1%

Some Confidence Is Lacking In PeterLabs Holdings Berhad's (KLSE:PLABS) P/E

Dec 16
Some Confidence Is Lacking In PeterLabs Holdings Berhad's (KLSE:PLABS) P/E
DPHARMA
RM 1.39
Duopharma Biotech Berhad
7D
6.1%
1Y
14.9%
KOTRA
RM 4.13
Kotra Industries Berhad
7D
-1.0%
1Y
-1.4%